Federal Register / Vol. 74, No. 75 / Tuesday, April 21, 2009 / Notices 18243 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group, Molecular 

Neuropharmacology and Signaling Study 

Section. 

Date: June 1–2, 2009. 

Time: 8 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: Deborah L. Lewis, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4118, 

MSC 7850, Bethesda, MD 20892, 301–435– 

1224, lewisdeb@csr.nih.gov. 

Name of Committee: Biobehavioral and 

Behavioral Processes, Integrated Review 

Group, Language and Communication Study 

Section. 

Date: June 1–2, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street, 

NW., Washington, DC 20036. 

Contact Person: Weijia Ni, PhD, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 3184, MSC 7848, Bethesda, MD 

20892, (301) 435–1507, niw@csr.nih.gov. 

Name of Committee: Oncology 2— 

Translational Clinical Integrated Review 

Group, Radiation Therapeutics and Biology 

Study Section. 

Date: June 1–2, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Bo Hong, PhD, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 6194, MSC 7804, Bethesda, MD 

20892, 301–435–5879, hongb@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Cardiac 

Hypertrophy. 

Date: June 1, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Maqsood A. Wani, DVM, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2114, 

MSC 7814, Bethesda, MD 20892, 301–435– 

2270, wanimaqs@csr.nih.gov. 

Name of Committee: Brain Disorders and 

Clinical Neuroscience, Integrated Review 

Group, Anterior Eye Disease Study Section. 

Date: June 1–2, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: Jerry L. Taylor, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5202, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1175, tayIorje@csr.nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior, Integrated Review Group, 

Psychosocial Risk and Disease Prevention 

Study Section. 

Date: June 1–2, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza Tysons Corner Hotel, 

1960 Chain Bridge Road, McLean, VA 22102. 

Contact Person: Martha Faraday, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3110, 

MSC 7808, Bethesda, MD 20892, 301–435– 

3575, faradaym@csr.nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group, 

Behavioral Medicine, Interventions and 

Outcomes Study Section. 

Date: June 1–2, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Rouge, 1315 16th Street, NW., 

Washington, DC 20036. 

Contact Person: Lee S. Mann, JD, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3186, 

MSC 7848, Bethesda, MD 20892, 301–435– 

0677, mannl@csr.nih.gov. 

Name of Committee: Brain Disorders and 

Clinical Neuroscience, Integrated Review 

Group, Neural Basis of Psychopathology, 

Addictions and Sleep Disorders Study 

Section. 

Date: June 1–2, 2009. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites Washington, DC, 

1250 22nd Street, NW., Washington, DC 

20037. 

Contact Person: Julius Cinque, MS, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5186, 

MSC 7846, Bethesda, MD 20892, (301) 435– 

1252, cinquej@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Microbiology, Integrated Review Group, 

Virology—B Study Section. 

Date: June 1–2, 2009. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Alexandria Old Town, 1767 

King Street, Alexandria, VA 22314. 

Contact Person: Robert Freund, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3200, 

MSC 7848, Bethesda, MD 20892, 301–435– 

1050, freundr@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: April 10, 2009. 

Anna Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–8895 Filed 4–20–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Injury Prevention 

and Control, Initial Review Group, 

(NCIPC, IRG) 

Correction: This notice was published 

in the Federal Register on April 13, 

2009, Volume 74, Number 69, Page 

16878. The times and participant pass 

code has been changed to the following: 

Times and Dates: 8 a.m.–8:15 a.m., April 

22, 2009 (Open); 8:15 a.m.–4 p.m., April 22, 

2009 (Closed). 

Place: Teleconference, toll free: (877) 468– 

4185, Participant. Passcode: 4475689. 

Contact Person For More Information: Jane 

Suen, Dr.P.H., M.S., NCIPC, CDC, 4770 

Buford Highway, NE., Mailstop F–62, 

Atlanta, Georgia 30341, Telephone: (770) 

488–4281. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: April 15, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–9188 Filed 4–20–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

mstockstill on PROD1PC66 with NOTICES

18244 Federal Register / Vol. 74, No. 75 / Tuesday, April 21, 2009 / Notices 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel. 

Review for Registry and Surveillance System 

in Hemoglobinopathies (RuSH) Pilot Studies. 

Date: May 11, 2009. 

Time: 9:30 a.m. to 2 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call). 

Contact Person: William J Johnson, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7178, 

Bethesda, MD 20892–7924. 301–435–0725. 

johnsonwj@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: April 15, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–9133 Filed 4–20–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of Meeting; Moving Into the 

Future—New Dimensions and 

Strategies for Women’s Health 

Research for the National Institutes of 

Health 

Notice is hereby given that the Office 

of Research on Women’s Health 

(ORWH), Office of the Director, National 

Institutes of Health, Department of 

Health and Human Services, in 

collaboration with the Department of 

Obstetrics, Gynecology and 

Reproductive Sciences at the University 

of California, San Francisco (UCSF), 

will convene a public hearing and 

scientific workshop on May 27–29, 

2009, at the UCSF, Mission Bay 

Conference Center, San Francisco, 

California. 

Purpose of the Meeting 

With rapid advances in science and 

wider global understanding of women’s 

health and sex/gender contributions to 

well-being and disease, the purpose of 

the meeting is to ensure that NIH 

continues to support cutting edge 

women’s health research that is based 

upon the most advanced techniques and 

methodologies. The meeting format is 

designed to promote an interactive 

discussion involving leading scientists, 

advocacy groups, public policy experts, 

health care providers, and the general 

public. The San Francisco meeting is 

the second in a series that will be 

convened throughout the Nation to 

assist the ORWH and the NIH to move 

into the next decade of women’s health 

research. 

As science and technology advance 

and fields such as computational 

biology demonstrate the power of 

interdisciplinary research, it remains 

critical for sex and gender factors to be 

integrated into broad experimental 

methodologies and scientific 

approaches such as stem cell research. 

Biomedical and behavioral research are 

also necessary to understand how 

cultural, ethnic, and racial differences 

influence the causes, diagnosis, 

progression, treatment, and outcome of 

disease among different populations, 

including women of diverse geographic 

locations and socioeconomic 

backgrounds. Furthermore, health 

differences among diverse populations 

of women remain a critical area in need 

of continued focus and attention. 

The ORWH challenges all meeting 

attendees to assist the NIH in defining 

the women’s health research agenda of 

the future, thinking beyond traditional 

women’s health issues. The attendees 

need to identify creative strategies and 

areas of research that are best poised for 

advancement, address innovative ways 

to approach persistent issues of health 

and disease, and explore new scientific 

concepts and investigative approaches. 

The attendees need to pay attention to 

new areas of science application, new 

technologies, and continuing basic 

science investigations. The attendees 

should also consider clinical questions 

that are not currently the focus of 

research priorities to ensure that 

women’s health research is optimally 

served and that the ORWH can continue 

to provide leadership for the benefit of 

women’s health, nationally and 

internationally. 

Meeting Format 

The meeting will consist of public 

testimony, scientific panels, and six 

concurrent scientific working groups. 

Specifically, on May 27, individuals 

representing a full spectrum of 

organizations interested in biomedical 

and behavioral research on women’s 

health issues will have an opportunity 

to provide public testimony from 2–6 

p.m. On May 28 and 29, plenary 

sessions will focus on the intersection of 

health care, public policy, and 

biomedical research; on emerging issues 

and trends in health care; and on 

research paradigms of the future. The 

six concurrent afternoon sessions on 

May 28 will focus on a range of research 

areas, including global health, stem cell 

research, environmental health and 

reproduction, HIV/AIDS and women, 

information technology, and women in 

biomedical careers. On May 29, the 

morning session will be devoted to 

reports by the working group co-chairs 

regarding the recommendations 

emerging from working group 

deliberations on the previous day. The 

meeting will adjourn at 1 p.m. on May 

29. 

Public Testimony 

ORWH invites individuals with an 

interest in research related to women’s 

health to provide written and/or oral 

testimony on these topics and/or on 

issues related to the sustained 

advancement of women in biomedical 

careers. Due to time constraints, only 

one representative from an organization 

or professional specialty group may 

submit oral testimony. Individuals not 

representing an organized entity but a 

personal point of view are similarly 

invited to present written and/or oral 

testimony. A letter of intent to present 

oral testimony is necessary and should 

be sent electronically to http:// 

www.orwhmeetings.com/ 

movingintothefuture/ or by mail to Ms. 

Jory Barone, Educational Services, Inc., 

4350 East-West Highway, Suite 1100, 

Bethesda, MD 20814, no later than May 

15, 2009. The date of receipt of the 

communication will establish the order 

of those selected to give oral testimony 

at the May meeting. 

Those wishing to present oral 

testimony are also asked to submit a 

written form of their testimony that is 

limited to a maximum of 10 pages, 

double spaced, 12 point font, and 

should include a brief description of the 

organization. Electronic submission to 

the above Web site is preferred; 

however, for those who do not have 

access to electronic means, written 

testimony, bound by the restrictions 

previously noted and postmarked no 

later than May 15, 2009, may be mailed 

to Ms. Jory Barone at the above address. 

All written presentations must meet the 

established page limitations. 

Submissions exceeding this limit will 

not be accepted and will be returned. 

Oral testimony of this material at the 

meeting will be limited to no more than 

5–7 minutes in length. 

Because of time constraints for oral 

testimony, testifiers may not be able to 

present the complete information as it is 

contained in their written form 

submitted for inclusion in the public 

record of the meeting. Therefore, 

mstockstill on PROD1PC66 with NOTICES